Alloy Therapeutics Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...
Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...
After an apparent accidental early release, Pfizer has revealed phase 1 data showing its investigational candidate, alongside ...
Recombinant antibodies are invented antibodies formed by using recombinant DNA technology. While traditional monoclonal ...
Intra-ImmuSG seeks to develop a safer and more effective cancer therapy via a combination of a targeted therapy and immunotherapy.
Advancements in Gene Editing Technology and Expansion of Oncology Research to Expand Demand for Humanized Mice ModelsRockville, MD, Jan. 30, 2025 (GLOBE NEWSWIRE) -- The humanized mice model market is ...
Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...
Ypsilon Therapeutics, a portfolio company of 82VS, Alloy’s venture studio, has been awarded $2.7 million in seed funding from ...
Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...
Collaboration to explore the immunoregulation of NK and T cells within the tumor microenvironment (TME) by CAPTN-3, with the goal of enhancing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback